This study involves patients who are having surgery to replace their knee joint, a procedure called total knee replacement, which is done to treat knee osteoarthritis. Knee osteoarthritis is a condition where the protective cartilage in the knee wears down over time, causing pain and stiffness. The study will use different types of nerve blocks, which are injections given near nerves to reduce pain after surgery. The medications being used are ropivacaine hydrochloride, which is a local pain-relieving medicine that numbs the area, and epinephrine, which is a substance that helps the pain medicine work longer. These medications will be given through injections near the nerves around the knee.
The purpose of the study is to compare two different methods of blocking pain to see which one works better for patients after knee replacement surgery. One method involves blocking the genicular nerves, which are small nerves around the knee joint. The other method combines two types of blocks: one called the adductor canal block, which numbs nerves in a passage on the inner side of the thigh, and another called the IPACK block, which stands for infiltration between the popliteal artery and the capsule of the knee, targeting the back of the knee. The study will measure pain levels using a scale where patients rate their pain from zero to ten, with zero being no pain and ten being the worst pain imaginable.
During the study, patients will receive one of these two pain-blocking methods before their knee replacement surgery. After the surgery, the study team will check how much pain patients feel at different times, including right after surgery, at twelve hours, at twenty-four hours during their first physical therapy session, and at forty-eight hours. The study will also look at how much additional pain medicine patients need, how well they can move their knee, and their overall recovery quality. The treatment with the nerve blocks happens once, on the day of surgery, and the total amount of medication given will not exceed seventy milligrams of ropivacaine hydrochloride and three hundred fifty micrograms of epinephrine.



Spain